Keyphrases
Schizophrenia
100%
Schizophrenic Patients
92%
Clozapine
85%
Functional Connectivity
66%
Antipsychotics
62%
Chronic Schizophrenia
57%
Motor Vehicle Accident
57%
Posttraumatic Stress Disorder
49%
Clozapine Treatment
32%
Affective Context
28%
Risperidone
28%
Network Dynamics
28%
Electroconvulsive Therapy
28%
Risky Decisions
28%
Global Functional Connectivity
28%
Medial Prefrontal Cortex (mPFC)
28%
Inhibition Capacity
28%
General Health
28%
Olanzapine
28%
Capacity Decision
28%
Behavioral State
28%
Cohesion Index
28%
Accident Victims
28%
Clinical Characteristics
28%
Long-term Antipsychotic Treatment
28%
Substance Abuse
28%
Outpatient Clinic
28%
Network Cohesion
28%
Demographic Characteristics
28%
Posttraumatic Stress Symptoms
28%
Overreporting
28%
Primary Care Setting
28%
Israel
28%
Early-onset Schizophrenia
28%
Randomized Trial
28%
Europe
28%
Long-acting Injectable Antipsychotics
28%
Embodied Simulation
23%
Long-acting Injectable
23%
All-cause Discontinuation
23%
Body Mass Index
21%
Inferior Frontal Gyrus
19%
Inhibition Control
19%
Corpus Callosum
19%
Theory of Mind
19%
Healthy Controls
18%
Combined Treatment
16%
Risky Decision Making
14%
Treatment Group
14%
Minnesota Multiphasic Personality Inventory-2 (MMPI-2)
12%
Neuroscience
Clozapine
85%
Functional Connectivity
66%
Antipsychotic
57%
Typical Antipsychotic
34%
Risperidone
28%
Prefrontal Cortex
28%
Electroconvulsive Therapy
28%
Olanzapine
28%
Posttraumatic Stress Disorder
28%
Theory of Mind
28%
Physical Dependence
28%
Psychopathology
19%
Corpus Callosum
19%
Inferior Frontal Gyrus
19%
Body Mass Index
14%
Decision-Making
14%
Paliperidone
14%
Dynamic Functional Connectivity
9%
Somatics
9%
Impulsivity
9%
Atypical Antipsychotic
8%
Functional Magnetic Resonance Imaging
7%
Negative Syndrome
7%
Positive Syndrome
7%
Akathisia
7%
Iowa Gambling Task
7%
Open-Label Trial
7%
Cognitive Function
7%
Mini-International Neuropsychiatric Interview
7%
Survival Analysis
7%
Parkinsonism
7%
Aripiprazole
7%
Psychiatry
7%